J Cancer 2017; 8(19):4002-4010. doi:10.7150/jca.21141 This issue Cite

Research Paper

Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis

Jiaxi He1,2,3*, Hui Pan1,2,3*, Wenhua Liang1,2,3, Dakai Xiao1,2,3, Xuewei Chen1,2,3, Minzhang Guo1,2,3, Jianxing He1,2,3✉

1. Department of Thoracic Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China;
2. Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease, Guangzhou, China
3. National Clinical Research Center for Respiratory Disease, Guangzhou, China;
*These authors contributed equally to this work.

Citation:
He J, Pan H, Liang W, Xiao D, Chen X, Guo M, He J. Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis. J Cancer 2017; 8(19):4002-4010. doi:10.7150/jca.21141. https://www.jcancer.org/v08p4002.htm
Other styles

File import instruction

Abstract

Background: Albumin and globulin are main components of serum protein. The level of albumin and globulin partially represents the nutrition status and immune system. Albumin-to-globulin ratio (AGR) has been reported as a prognostic factor in various cancers. We therefore performed a meta-analysis to elucidate the prognosis effect of AGR on survival outcomes in solid tumors.

Method: Six electronic database were searched for the relevant articles that assessing the prognostic value of pre-treatment AGR in solid tumor patients. The primary outcome was overall survival (OS) and the secondary outcomes were cancer-specific survival (CSS), disease-free survival (DFS) and disease-metastasis-free survival (DMFS). The time-to-event outcomes were summarized in hazard ratio (HR) and 95% confidence interval (CI).

Result: A total of 13890 solid tumor patients in 24 studies were included. The AGR higher than the cut-off values ranging from 1.15-1.75 was related to better OS (HR=0.58, 95%CI 0.537-0.626, p<0.0001), CSS (HR=0.287, 95%CI 0.187-0.438, p<0.0001), DFS (HR=0.792, 95%CI 0.715-0.878, p<0.0001) and DMFS (HR=0.595, 95%CI 0.447-0.792, p<0.0001). According to the cut-off values, subgroup analysis showed that AGR had significant prognostic effect on OS in each cut-off intervals (≤1.20, 1.20-1.40 and ≥1.40).

Conclusion: Pre-treatment AGR is an effective prognostic factor and high AGR represents an ideal clinical outcome in the solid tumor patients.

Keywords: meta-analysis, prognosis, survival, solid tumor, albumin-to-globulin ratio(AGR)


Citation styles

APA
He, J., Pan, H., Liang, W., Xiao, D., Chen, X., Guo, M., He, J. (2017). Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis. Journal of Cancer, 8(19), 4002-4010. https://doi.org/10.7150/jca.21141.

ACS
He, J.; Pan, H.; Liang, W.; Xiao, D.; Chen, X.; Guo, M.; He, J. Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis. J. Cancer 2017, 8 (19), 4002-4010. DOI: 10.7150/jca.21141.

NLM
He J, Pan H, Liang W, Xiao D, Chen X, Guo M, He J. Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis. J Cancer 2017; 8(19):4002-4010. doi:10.7150/jca.21141. https://www.jcancer.org/v08p4002.htm

CSE
He J, Pan H, Liang W, Xiao D, Chen X, Guo M, He J. 2017. Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis. J Cancer. 8(19):4002-4010.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image